We are live on ! Find out more
NGM

NGM Biopharmaceuticals, Inc. Common Stock
NGM

Delisted

NGM was delisted on the 4th of April, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of NGM yet.

NGM Hedge Fund Activity: Q2 2024 in Review

0 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in NGM Biopharmaceuticals, Inc. Common Stock (NGM) for Q2 2024, worth a combined $0 — down 100% from $55.1M a quarter earlier.

Sellers outnumbered buyers: 74 funds closed out of NGM and 0 opened new positions — a net loss of 74 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Column Group, exiting entirely with an estimated $28.8M sold.

  • 0 institutional investors held NGM Biopharmaceuticals, Inc. Common Stock (NGM) as of Q2 2024, down from 75 in Q1 2024.
  • Funds reported $0 of NGM Biopharmaceuticals, Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new NGM Biopharmaceuticals, Inc. Common Stock positions in Q2 2024 and 74 closed out, a net change of -74 holders.
  • The largest NGM Biopharmaceuticals, Inc. Common Stock seller in Q2 2024 was Column Group, an estimated $28.8M sold.

Based on aggregated 13F filings for Q2 2024.